Home›People›Jason Hafler
JH

Jason Hafler

Managing director at Sanofi Ventures; director at Matchpoint Therapeutics.

DirectorRoles at 2 startups
Updated Nov 20, 2026·Latest SEC filing Nov 20, 2026·Suggest an edit

About Jason Hafler

Jason Hafler is a managing director at Sanofi Ventures, Sanofi’s corporate venture capital arm. He is also a Matchpoint Therapeutics director. Matchpoint develops small-molecule medicines for immune diseases. He joined Abcuro’s board in January 2021.

He began at Sanofi Ventures in 2014 and became managing director in November 2019. Before Sanofi, he was RaNA Therapeutics’ director of corporate development from 2012 to 2014. He was an Atlas Venture associate from 2010 to 2012 and a Flagship Ventures entrepreneurial fellow in 2010. Earlier, he advised Cambridge’s technology transfer office and worked at JSB Partners. He joined Icosavax’s board in August 2019. His departure was planned for just before Icosavax’s registration became effective. In July 2021, he also served on boards at Buckingham Browne and Nichols School, the Magdalene College Foundation and Beacon Hill Nursery School. He completed an honors bachelor’s degree at Bowdoin College and a doctorate at the University of Cambridge.

Experience

This experience comes from official bios, from Jason Hafler's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jason Hafler in the role, so the role may have started earlier or lasted longer.

Matchpoint Therapeutics Inc. Current
Director; Managing Director, Sanofi Ventures
2022 – Present · Watertown, MA
Matchpoint develops oral drugs that bind hard-to-treat protein targets in immune diseases.
Abcuro, Inc. Current
Director
2021 – Present · Newton, MA
Develops immunotherapies for people with autoimmune diseases and cancer.
Sanofi Ventures Current
Managing Director
2019 – Present
Buckingham, Browne & Nichols Current
Board of Trustees
2011 – Present
Madgalene College Foundation Current
Member Board of Directors
2011 – Present
Beacon Hill Nursery School
Member Board of Trustees
2018 – 2021
Icosavax, Inc.
Director
From 2019
RaNA Therapeutics LLC
Director of Corporate Development
2012 – 2014
Bowdoin College
Fund Directors Board
2010 – 2013
Atlas Venture
associate
2010 – 2012
Flagship Ventures
Entrepreneurial Fellow
2010
University of Cambridge technology transfer office
JSB Partners LP
analyst

Key Colleagues at Startups

The people Jason Hafler works with at each company, as listed on that company's latest Form D.

Matchpoint Therapeutics Inc. · Form D, Nov 20, 2026
Andre Turenne
Andre Turenne
Director; President & Chief Executive Officer
BM
Brian Matesic
Director; Principal, Norwest
KP
Kanishka Pothula
Director; Managing Partner, Nextech
BB
Bruce Booth
Chairman; Partner, Atlas Venture
DB
Daniel Becker
Director; Managing Director, Access Biotechnology
DN
Jared Cumming
Jared Cumming
Chief Scientific Officer
John O'Malley
John O'Malley
Chief Medical Officer
Abcuro, Inc. · Form D, Feb 19, 2025
JM
John Martin
Chief Executive Officer and director
Sarah Boyce
Sarah Boyce
Director
MP
Michele Park
Director
Mark Pruzanski
Mark Pruzanski
Chairman of the Board
RS
Rajeev Shah
Director
Ming Fang
Ming Fang
Managing Director, Redmile Group
Michael Dybbs
Michael Dybbs
Partner, Samsara BioCapital and director

Jason Hafler in the News

Sources

  1. SECMatchpoint Therapeutics Inc. Form D, filed Nov 20, 2026
  2. SECAbcuro, Inc. Form D, filed Feb 19, 2025
  3. P3Abcuro financing announcement
  4. P4Icosavax registration statement